Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer
- PMID: 15065600
- DOI: 10.1023/b:clin.0000017168.83616.d0
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer
Abstract
Tumour endothelial markers (TEMs) are a newly discovered family of endothelial markers associated with tumour specific angiogenesis. This study sought to examine the levels of expression for TEMs in human breast cancer. Breast cancer tissues (n = 120) together with normal background tissues (n = 33) were obtained after surgery. RNA was extracted from frozen sections for gene amplification. The expression of TEMs was assessed using RT-PCR and the quantity of their transcripts was determined using real-time-quantitative PCR (Q-RT-PCR). TEM-7R (P = 0.05) and TEM-8 (P < 0.01) were significantly raised in breast cancer tissues compared with the levels detected in normal background tissues. After a median follow-up of 72.2 months it was found that patients who had recurrent disease and/or who had died from breast cancer had a significantly (P < 0.05) elevated level of TEM-1 compared to those patients who were disease free. In addition, elevated levels of TEM-4, TEM-5, TEM-6, TEM-7 and TEM-7R were also raised in breast cancer tissues. Patients who had developed nodal involvement exhibited significantly (P < 0.05) high levels of TEM-1 and TEM-7R compared to patients who were node negative. Furthermore, the levels of TEMs did not correlate with tumour or histological grade. We conclude that elevated levels of TEM-1, TEM-7R and TEM-8 (but not TEM-2, 4, 5, 6 and 7) are associated with either nodal involvement, and/or disease progression, and may therefore, have a prognostic value in breast cancer.
Similar articles
-
Prognostic values of tumor endothelial markers in patients with colorectal cancer.World J Gastroenterol. 2005 Mar 7;11(9):1283-6. doi: 10.3748/wjg.v11.i9.1283. World J Gastroenterol. 2005. PMID: 15761964 Free PMC article.
-
Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.Int J Oncol. 2006 Nov;29(5):1311-7. Int J Oncol. 2006. PMID: 17016666
-
Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.Eur J Surg Oncol. 2004 Nov;30(9):948-53. doi: 10.1016/j.ejso.2004.07.023. Eur J Surg Oncol. 2004. PMID: 15498639
-
Prognostic value of tumour endothelial markers in patients with endometrial cancer.Oncol Lett. 2010 Jan;1(1):203-207. doi: 10.3892/ol_00000037. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966283 Free PMC article.
-
Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.Int J Cancer. 2005 Dec 10;117(5):730-7. doi: 10.1002/ijc.21221. Int J Cancer. 2005. PMID: 15957166
Cited by
-
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.J Clin Invest. 2014 Apr;124(4):1497-511. doi: 10.1172/JCI67382. Epub 2014 Mar 18. J Clin Invest. 2014. PMID: 24642465 Free PMC article.
-
PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B.Clin Exp Metastasis. 2022 Aug;39(4):691-710. doi: 10.1007/s10585-022-10168-5. Epub 2022 Jun 4. Clin Exp Metastasis. 2022. PMID: 35661947 Free PMC article.
-
TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.BMC Cancer. 2014 Feb 20;14:113. doi: 10.1186/1471-2407-14-113. BMC Cancer. 2014. PMID: 24555435 Free PMC article.
-
Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan.Front Oncol. 2020 Jan 17;9:1482. doi: 10.3389/fonc.2019.01482. eCollection 2019. Front Oncol. 2020. PMID: 32010611 Free PMC article. Review.
-
Plxdc2 is a mitogen for neural progenitors.PLoS One. 2011 Jan 21;6(1):e14565. doi: 10.1371/journal.pone.0014565. PLoS One. 2011. PMID: 21283688 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous